scanX
Home
Laurus Labs

Laurus Labs

487.75
-1.25
(-0.26%)
Market Cap (₹ Cr.)
₹26,373
52 Week High
518.00
Book Value
₹76
52 Week Low
360.85
PE Ratio
201.30
PB Ratio
6.38
PE for Sector
37.21
PB for Sector
3.95
ROE
4.09 %
ROCE
7.95 %
Dividend Yield
0.16 %
EPS
₹2.75
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-16.20 %
Net Income Growth
-78.89 %
Cash Flow Change
-33.02 %
ROE
-79.23 %
ROCE
-69.65 %
EBITDA Margin (Avg.)
-39.98 %

Financial Results

Quarterly Financials
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
452
484
410
524
514
476
480
540
484
552
534
585
514
619
546
707
723
831
977
1,134
1,281
1,404
1,228
1,181
940
1,380
1,498
1,502
1,504
1,285
1,114
1,164
1,143
1,439
1,126
1,197
Expenses
350
363
320
406
403
349
377
422
387
432
453
499
427
505
458
567
570
636
706
759
858
936
858
842
717
1,005
1,077
1,072
1,116
1,027
980
978
962
1,143
956
1,003
EBITDA
102
122
90
118
111
127
103
118
96
119
81
86
87
114
88
140
153
194
271
375
423
468
371
338
223
375
421
430
388
258
135
186
181
295
171
194
Operating Profit %
21 %
25 %
22 %
21 %
20 %
25 %
20 %
21 %
18 %
21 %
15 %
13 %
17 %
18 %
15 %
20 %
21 %
23 %
27 %
33 %
33 %
33 %
30 %
28 %
23 %
27 %
28 %
28 %
26 %
20 %
12 %
16 %
15 %
19 %
14 %
15 %
Depreciation
24
25
25
25
27
27
29
29
30
34
37
39
42
43
45
47
47
45
48
49
49
51
55
59
60
61
66
76
78
81
84
85
87
89
91
91
Interest
29
29
28
25
30
15
18
18
17
23
22
24
23
17
22
25
20
20
15
13
17
21
25
21
21
29
28
38
39
41
33
38
38
42
41
45
Profit Before Tax
49
68
38
68
55
85
57
71
50
63
22
23
22
54
21
68
86
129
209
312
357
396
290
258
142
285
328
317
270
137
17
63
57
164
39
58
Tax
9
25
8
15
12
19
14
15
11
14
5
3
5
12
5
11
15
22
55
81
88
111
51
67
38
76
103
89
71
7
6
18
17
46
17
22
Net Profit
40
53
30
51
46
73
40
50
36
46
16
18
17
44
17
60
78
113
159
238
267
293
222
198
109
221
232
227
199
102
13
47
43
121
29
42
EPS in ₹
6.38
8.47
19.03
5.45
4.64
6.88
3.83
4.77
3.38
4.37
1.50
1.66
1.65
4.13
1.60
1.12
1.46
2.11
2.97
4.44
4.98
5.46
4.14
3.68
2.04
4.11
4.31
4.23
3.71
1.89
0.24
0.87
0.79
2.25
0.53
0.79
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,898
2,229
2,673
3,008
3,318
3,739
5,625
6,609
6,958
7,667
Fixed Assets
801
1,014
1,193
1,448
1,599
1,694
1,818
2,186
2,884
3,036
Current Assets
862
997
1,156
1,229
1,434
1,785
3,041
3,205
3,171
3,517
Capital Work in Progress
107
70
143
163
107
67
324
755
357
156
Investments
0
26
51
52
58
58
319
362
384
635
Other Assets
990
1,119
1,286
1,345
1,554
1,920
3,164
3,306
3,333
3,841
Total Liabilities
1,169
1,356
1,317
1,494
1,727
1,924
2,913
3,220
2,901
3,460
Current Liabilities
804
873
1,117
1,268
1,379
1,637
2,352
2,434
2,106
2,736
Non Current Liabilities
365
483
200
226
348
287
561
786
795
725
Total Equity
729
872
1,356
1,513
1,591
1,816
2,712
3,388
4,057
4,207
Reserve & Surplus
647
790
1,250
1,407
1,484
1,709
2,605
3,281
3,949
4,099
Share Capital
82
82
106
106
106
107
107
107
108
108
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
21
-27
-8
0
-0
0
38
2
-39
41
Investing Activities
-406
-315
-282
-417
-257
-217
-900
-837
-735
-757
Operating Activities
-59
197
321
369
293
345
694
823
882
659
Financing Activities
486
90
-47
49
-37
-127
243
15
-185
139
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
27.45 %
27.30 %
27.30 %
27.27 %
27.27 %
27.27 %
27.27 %
27.20 %
27.20 %
27.20 %
27.20 %
27.19 %
27.19 %
27.18 %
27.18 %
FIIs
20.68 %
21.50 %
22.78 %
22.06 %
22.43 %
21.96 %
22.65 %
21.89 %
22.40 %
22.52 %
24.03 %
25.39 %
25.97 %
25.67 %
26.08 %
DIIs
3.56 %
4.19 %
4.85 %
6.92 %
7.95 %
9.13 %
9.35 %
9.53 %
9.76 %
10.35 %
11.01 %
11.14 %
11.77 %
13.56 %
13.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
48.31 %
47.01 %
45.06 %
43.76 %
42.36 %
41.65 %
40.73 %
41.39 %
40.64 %
39.93 %
37.76 %
36.29 %
35.07 %
33.59 %
33.69 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,767.00 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,460.45 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,527.65 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,192.45 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
942.05 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,040.05 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,219.60 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,586.05 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,464.05 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,569.40 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
54.06
ATR(14)
Less Volatile
15.72
STOCH(9,6)
Neutral
35.75
STOCH RSI(14)
Neutral
31.95
MACD(12,26)
Bearish
-0.72
ADX(14)
Weak Trend
16.11
UO(9)
Bearish
45.04
ROC(12)
Uptrend And Accelerating
0.76
WillR(14)
Neutral
-53.33
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.